Article 1 Purpose

Livzon Pharmaceutical Group Co., Ltd. and its subsidiaries (hereinafter"the Group"or"we") are committed to conducting all sales and marketing activities in a responsible, ethical, and patient-centered manner. To this end, this Responsible Marketing Policy (hereinafter"this Policy") is formulated to regulate our sales and marketing activities in markets around the world.

Article 2 Scope of Application

This Policy applies to the Group and all its employees (including full-time, part-time, and temporary employees). Each unit of the Group shall fully comply with this Policy when formulating its internal marketing system.

Article 3 Compliance with Laws and Internal Regulations

Any form of sales and marketing activities conducted by the Group must comply with all applicable laws, regulations, and industry standards in the place of operation, including but not limited to the "Drug Administration Law of the People's Republic of China," "Anti-Unfair Competition Law of the People's Republic of China," "Advertising Law of the People's Republic of China," "Personal Information Protection Law of the People's Republic of China," and the "General Data Protection Regulation" (GDPR), and must also comply with the internal sales, marketing, and advertising regulations established by the Group.

Article 4 Basic Principles

Any form of sales and marketing activities, including content, methods, and related materials, must be truthful, accurate, and compliant, specifically including:

1. Establishing a strict review and supervision mechanism, which must go through external and internal audits and approvals, and continuous supervision.
2. Promotional materials for clinical efficacy must be based on data from formally published journal literature, ensuring that the content is truthful, accurate, and compliant.
3. It is strictly prohibited to include exaggerated, misleading, deceptive, or false content.
4. It is strictly prohibited to intervene in or influence the rational use of drugs in clinical settings.
5. It is strictly prohibited to conceal known adverse reactions and other risks of products, and feedback must be timely, truthful, and accurate.
6. Honesty and integrity, fair competition.
7. Information should maintain consistency across different channels.
8. Maintain good business ethics when communicating and interacting with customers and healthcare professionals, and it is strictly prohibited to use commercial bribery or other illegal means for sales and marketing activities.
9. Strictly protect customer privacy, and without the customer's knowledge and consent, do not disclose customer privacy and information.

Article 5 Responsible Marketing Audit

We regularly conduct responsible marketing audits to ensure that the Group's sales and marketing activities and related third-party service providers comply with our policies and regulations.

Article 6 Responsible Marketing Training

We regularly provide responsible marketing training for all employees to continuously enhance their professional knowledge, capabilities, and professional ethics in responsible marketing.

Article 7 Reporting Violations

If any behavior that may violate laws and regulations and the Group's relevant policies and regulations is discovered, any employee, customer, supplier, and service provider has the right to report. For reporting channels and procedures, please refer to the "Livzon Pharmaceutical Group Co., Ltd. Reporting and Complaint Management Measures" (published on the company's official website), and we will handle, investigate, and process accordingly, strictly keeping the personal information and reporting content of the whistleblower confidential, fully protecting the legitimate rights and interests of the whistleblower. If the investigation confirms that the report is true, we will seriously handle it according to relevant procedures, punish the responsible person, and take necessary corrective measures.

Article 8 Others

This Policy has been reviewed and approved by the board of directors' subordinateESGCommittee ("ESGthe Committee"ESG). The Committee regularly reports to the board of directors on the implementation of this Policy and provides suggestions for the board's decision-making and supervision.

ESGThe Committee has full responsibility for executing, supervising, and regularly reviewing this Policy.ESGThe Committee is responsible for the interpretation and revision of this Policy.

Matters not covered in this Policy shall be executed in accordance with relevant laws, regulations, and normative documents.

This Policy shall take effect from the date of promulgation.

Livzon Pharmaceutical Group Co., Ltd.